LIG아큐버 Stock: price and insider trades · South Korea

LIG아큐버 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). The last twelve months, up to 18 October 2026, brought 3 filings signed by 3 insiders.

The flow runs one way only: 2 insiders bought (2 purchases totalling €87k) and nobody sold on the market. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 chief executive. At €87k, the purchase published on 30 April 2026 by 허순재 is the largest of the period (0.058% of market cap).

The clock since the last published purchase (30 April 2026) now reads 171 days.

For context, the typical company on the same exchange (median of 2,648 companies) published 7 filings over the same period, against 3 filings here. Looking back to 2021, when coverage begins, insiders filed 23 purchases and 1 sale.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.